Mycosynthetix CEO Dr. Cedric Pearce was featured on the May 8, 2013 edition of Radio In Vivo, a weekly broadcast that features in-depth interviews with the researchers who make the Research Triangle of North Carolina one of the world’s leading hubs of scientific research and development. In the interview, Dr. Pearce discusses the origins of Mycosythetix, [...]
New Website Launched
Mycosynthetix is pleased to present our new website. If you encounter any problems using our website, please don’t hesitate to let us know.
Mycosynthetix Celebrates 10 Years
We are pleased to celebrate 10 years of Mycosynthetix. We look forward to further developing the potential for world-changing natural products from the fungal kingdom in the coming decade.
Mycosynthetix Awarded 2 Therapeutic Discovery Project Grants
Mycosynthetix, Inc has been awarded two Therapeutic Discovery Project Grants by the IRS. The grants are for projects that “showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness.”
Antimalarial Constituents of Microorganisms
Mycosynthetix CEO, Dr. Cedric Pearce, and colleagues presented at the 51st Annual Meeting of the American Society of Pharmacognosy in Tampa, Florida this July. Their presentation focused on the antimalarial compounds which have been discovered within microorganisms, such as the fungi in the Mycosynthetix library.
Green Ethanol from Biomass? Verenium Looks to Mycosynthetix Fungi
“Fungi are the most prolific degraders of plant biomass in nature and are expected to hold the keys to unlocking the potential of cellulose as a renewable feedstock.” Shortly after the posting of this release, Verenium’s biofuels division was acquired by British Petroleum. Mycosynthetix’ contract has been transferred to BP in the exchange.
Mycosynthetix Awarded an SBIR Grant to Work on New Tuberculosis Antibiotics
Mycosynthetix, Inc. was recently awarded a Phase I Small Business Innovation Research grant from the National Institutes of Allergy and Infectious Diseases for the project New Tuberculosis Antibiotics from Filamentous Fungi.
Mevalocidin – novel natural herbicide under development
Mycosynthetix is currently developing Mevalocidin, a new herbicidal natural product from fungal fermentation, for use in organic farming. The US Patent for Mevalocidin (PDF) was issued on July 1st, 2008. Dow AgroSciences LLC of Indianapolis and Mycosynthetix Inc have entered into a royalty-bearing agreement for Mycosynthetix to develop and market this herbicide. Contact Dr. Cedric [...]